BDX vs IOVA · P/E 34, rev $21.84B vs rev $170.7M
Becton Dickinson and Company (BDX) versus Iovance Biotherapeutics Inc (IOVA) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Iovance Biotherapeutics Inc (IOVA) is a biotechnology company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported IOVA revenue for 2026-06-30 was $170.7M. Net income was -$126.4M. IOVA currently screens at market cap $1.89B.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. IOVA currently screens at market cap $1.89B.
Not investment advice. Open the BDX and IOVA stock pages for the full models.
Not investment advice.